| Jan 17, 2025 |
Jan 17, 2025 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-5,584
|
-42.65%
|
✗
|
$3.2K |
| Jan 13, 2025 |
Jan 15, 2025 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-19,542
|
-41.79%
|
✗
|
$11.4K |
| Jan 16, 2024 |
Jan 17, 2024 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-22,795
|
-40.26%
|
✗
|
$15.9K |
| Jan 11, 2024 |
Jan 12, 2024 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-9,229
|
-39.77%
|
✗
|
$7.8K |
| Aug 1, 2023 |
Aug 1, 2023 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-3,096
|
-39.62%
|
✗
|
$2.8K |
| Jan 17, 2023 |
Jan 17, 2023 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-4,440
|
-37.94%
|
✗
|
$8.2K |
| Jan 11, 2023 |
Jan 12, 2023 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-8,816
|
-37.99%
|
✗
|
$15.2K |
| Jan 4, 2023 |
Jan 4, 2023 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,100
|
-38.94%
|
✗
|
$1.9K |
| Aug 1, 2022 |
Aug 1, 2022 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-2,983
|
-38.18%
|
✗
|
$5.3K |
| Jul 5, 2022 |
Jul 5, 2022 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,973
|
-38.86%
|
✗
|
$3.3K |
| Jan 18, 2022 |
Jan 18, 2022 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-4,368
|
-37.32%
|
✗
|
$13.9K |
| Jan 11, 2022 |
Jan 13, 2022 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-4,846
|
-37.46%
|
✗
|
$17.2K |
| Jan 4, 2022 |
Jan 5, 2022 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,070
|
-37.88%
|
✗
|
$4.3K |
| Aug 2, 2021 |
Aug 2, 2021 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-2,939
|
-37.62%
|
✗
|
$10.5K |
| Jul 2, 2021 |
Jul 2, 2021 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,907
|
-37.56%
|
✗
|
$8.1K |
| Jan 19, 2021 |
Jan 19, 2021 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-4,358
|
-37.24%
|
✗
|
$24.7K |
| Jan 12, 2021 |
Jan 12, 2021 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,058
|
-37.45%
|
✗
|
$6.5K |
| Jan 4, 2021 |
Jan 5, 2021 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,065
|
-37.70%
|
✗
|
$5.7K |
| Aug 3, 2020 |
Aug 4, 2020 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
46.3
|
-4,823
|
-37.42%
|
✗
|
$44.6K |
| Jan 14, 2020 |
Jan 15, 2020 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,144
|
-40.50%
|
✗
|
$5.9K |
| Jan 6, 2020 |
Jan 7, 2020 |
Adaptimmune Therapeutics PLC
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,148
|
-40.64%
|
✗
|
$1.4K |